CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY PADA SYSTEMIC LUPUS ERYTHEMATOSUS DENGAN ANA-IF NEGATIF
CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEGATIVE ANA-IF
Abstract
Systemic Lupus Erythematosus (SLE) merupakan penyakit autoimun sistemik yang dapat melibatkan berbagai organ, termasuk sistem saraf perifer. Salah satu manifestasi neurologis yang jarang ditemukan adalah Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), yang dapat muncul sebelum, bersamaan, atau setelah diagnosis SLE ditegakkan. Seorang wanita berusia 45 tahun datang dengan keluhan kesemutan progresif pada kedua tangan dan kaki sejak tiga bulan, disertai kelemahan anggota gerak yang memberat sehingga mengganggu kemampuan berjalan dan memegang barang. Pemeriksaan fisik menunjukkan kelemahan motorik pada keempat ekstremitas, penurunan refleks fisiologis, stocking hipoestesia, ulkus oral, serta ruam kemerahan pada kedua tangan. Pemeriksaan laboratorium menunjukkan trombositopenia, hematuria, peningkatan parameter inflamasi, serta kadar komplemen C3 dan C4 yang menurun. Hasil pemeriksaan ANA immunofluorescence (ANA IF) dan anti-double stranded DNA (anti-dsDNA) didapatkan negatif. Diagnosis SLE pada pasien ini ditegakkan berdasarkan kombinasi manifestasi klinis dan temuan laboratorium meskipun hasil ANA IF dan anti-dsDNA negatif. Kasus ini menunjukkan bahwa CIDP dapat menjadi manifestasi neurologis yang jarang pada SLE. Pengenalan dini keterlibatan saraf perifer sangat penting untuk menunjang diagnosis dan penatalaksanaan yang tepat sehingga dapat memperbaiki prognosis pasien.
References
Justiz VAA, Goyal A, Varacallo MA. StatPearls: Systemic Lupus Erythematosus. StatPearls Publisher; 2026.
Ameer MA, Chaudhry H, Mushtaq J, et al. An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management. Cureus. 2022;14(10):e30330.
Dai X, Fan Y, Zhao X. Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics. Signal Transduct Target Ther. 2025;10(1):102.
Gogia B, Rocha Cabrero F, Khan Suheb MZ. StatPearls: Chronic Inflammatory Demyelinating Polyradiculoneuropathy. StatPearls Publisher; 2024.
Sastre Martínez AD, Tróchez Ortiz MJ, Zuluaga Gómez LV, Messu Llano CD. Chronic Inflammatory Demyelinating Polyneuropathy as the Initial Presentation of Systemic Lupus Erythematosus Successfully Treated With Cyclophosphamide. Cureus. 2024;16(1):e51648.
Marques-Gomes C, Diz-Lopes M, Braz L, et al. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome. Semin Arthritis Rheum. 2025;34(3):312-315.
Julio PR, Cortês MMM, Costallat LTL, Gaino JZ, Franca MC Jr, Appenzeller S. Chronic Inflammatory Demyelinating Polyradiculoneuropathy Associated With Systemic Lupus Erythematosus. Semin Arthritis Rheum. 2021;51(1):158-165.
Bathina A, Chintada DC, Yellu NKR, Vijayashree J, Khatija Begum M, Unnikrishnan P. Clinical and Hematological Manifestations of Systemic Lupus Erythematosus at Initial Presentation in a Tertiary Healthcare Center. Cureus. 2024;16(12):e75956.
Siegel CH, Sammaritano LR. Systemic Lupus Erythematosus: A Review. JAMA. 2024;331(17):1480-1491.
Shiozawa S. Pathogenesis of Autoimmunity/Systemic Lupus Erythematosus (SLE). Cells. 2025;14(14):1080.
Su X, Yu H, Lei Q, et al. Systemic lupus erythematosus: pathogenesis and targeted therapy. Mol Biomed. 2024;5(1):54.
Karam C. Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Five New Things. Neurol Clin Pract. 2022;12(3):258-262.
Hamidi BL, Mirawati DK, Rahayu RF, Prabaningtyas HR, Hafizhan M, Putra SE. Chronic inflammatory demyelinating polyradiculoneuropathy associated with neuromyelitis optica spectrum disorder: A rare case report. Prev Med Rep. 2024;42:102702.
Arvin-Berod C, Brackx F, van de Veire L, et al. The journey to diagnosis for patients with CIDP: results from a real-world international survey. Front Neurol. 2026;16:1748903.
Querol L, Rinaldi S, Borsi A, et al. Real-World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape. J Peripher Nerv Syst. 2025;30(3):e70047.
Lerkvaleekul B, Chobchai P, Rattanasiri S, Vilaiyuk S. Evaluating performance of the 2019 EULAR/ACR, 2012 SLICC, and 1997 ACR criteria for classifying adult-onset and childhood-onset systemic lupus erythematosus: A systematic review and meta-analysis. Front Med (Lausanne). 2022; 9: 1093213.
Katkowska M, Łosoś M, Tarnacka B. Systemic lupus erythematosus and critical illness polyneuropathy. Reumatologia. 2021;59(4):265-269.
Rajabally YA, Freiha J, Min YG, Osman C. Very High Dose Immunoglobulin Treatment for Chronic Inflammatory Demyelinating Polyneuropathy: A Multicentre UK Study. Eur J Neurol. 2025;32(11):e70429.
Anderson-Smits C, Ritchey ME, Huang Z, et al. ntravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database Analysis. Eurol Ther. 2023;12(4):1119-1132.
Yu Z, Xue Y, Luo H, et al. Subacute-Aggressive-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy as the Initial Presentation in a Pediatric Patient With Systemic Lupus Erythematosus: A 5-Year Follow-Up Case Report. Pediatr Discov. 2025;3(3):e70028.
Smith K, Nathoo R, Foss MG. Subacute cutaneous lupus erythematosus secondary to intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy: A case report. JAAD Case Rep. 2025;69:74-77.
Copyright (c) 2027 Anggia Fitria Agustin, Deshinta Putri Mulya

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

